Maturation of tertiary lymphoid structures and recurrence of stage II and III colorectal cancer
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Maturation of tertiary lymphoid structures and recurrence of stage II and III colorectal cancer
Authors
Keywords
-
Journal
OncoImmunology
Volume 7, Issue 2, Pages e1378844
Publisher
Informa UK Limited
Online
2017-09-15
DOI
10.1080/2162402x.2017.1378844
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The immune contexture in cancer prognosis and treatment
- (2017) Wolf H. Fridman et al. Nature Reviews Clinical Oncology
- The relationships between serum cytokine levels and tumor infiltrating immune cells and their clinical significance in colorectal cancer
- (2016) Juha P. Väyrynen et al. INTERNATIONAL JOURNAL OF CANCER
- Blood-Based Biomarkers Are Associated with Disease Recurrence and Survival in Gastrointestinal Stroma Tumor Patients after Surgical Resection
- (2016) Michael Stotz et al. PLoS One
- The tumor microenvironment and Immunoscore are critical determinants of dissemination to distant metastasis
- (2016) Bernhard Mlecnik et al. Science Translational Medicine
- Colorectal cancer tumour markers and biomarkers: Recent therapeutic advances
- (2016) Gustaw Lech WORLD JOURNAL OF GASTROENTEROLOGY
- Global Cancer Incidence and Mortality Rates and Trends--An Update
- (2015) L. A. Torre et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Hemoglobin, alkalic phosphatase, and C-reactive protein predict the outcome in patients with liposarcoma
- (2015) Joannis Panotopoulos et al. JOURNAL OF ORTHOPAEDIC RESEARCH
- PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
- (2015) Dung T. Le et al. NEW ENGLAND JOURNAL OF MEDICINE
- Occurrence of Tertiary Lymphoid Tissue Is Associated with T-Cell Infiltration and Predicts Better Prognosis in Early-Stage Colorectal Cancers
- (2014) G. Di Caro et al. CLINICAL CANCER RESEARCH
- B Cells and Ectopic Follicular Structures: Novel Players in Anti-Tumor Programming with Prognostic Power for Patients with Metastatic Colorectal Cancer
- (2014) Anastasia Meshcheryakova et al. PLoS One
- A derived neutrophil to lymphocyte ratio predicts clinical outcome in stage II and III colon cancer patients
- (2013) G Absenger et al. BRITISH JOURNAL OF CANCER
- A structural equation modelling approach to explore the role of B vitamins and immune markers in lung cancer risk
- (2013) Valéria Troncoso Baltar et al. EUROPEAN JOURNAL OF EPIDEMIOLOGY
- Towards the introduction of the ‘Immunoscore’ in the classification of malignant tumours
- (2013) Jérôme Galon et al. JOURNAL OF PATHOLOGY
- Microsatellite Instability and BRAF Mutation Testing in Colorectal Cancer Prognostication
- (2013) Paul Lochhead et al. JNCI-Journal of the National Cancer Institute
- Colorectal cancer
- (2013) Hermann Brenner et al. LANCET
- A systematic review and meta-analysis on the impact of pre-operative neutrophil lymphocyte ratio on long term outcomes after curative intent resection of solid tumours
- (2013) Ashvin Paramanathan et al. SURGICAL ONCOLOGY-OXFORD
- Tertiary lymphoid organs in infection and autoimmunity
- (2012) Katrijn Neyt et al. TRENDS IN IMMUNOLOGY
- Statistical methods for analyzing immunosignatures
- (2011) Justin R Brown et al. BMC BIOINFORMATICS
- Optimized Allele-Specific Real-Time PCR Assays for the Detection of Common Mutations in KRAS and BRAF
- (2011) Alois H. Lang et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- Lymphocytic Reaction to Colorectal Cancer Is Associated with Longer Survival, Independent of Lymph Node Count, Microsatellite Instability, and CpG Island Methylator Phenotype
- (2009) S. Ogino et al. CLINICAL CANCER RESEARCH
- Prognostic Role of KRAS and BRAF in Stage II and III Resected Colon Cancer: Results of the Translational Study on the PETACC-3, EORTC 40993, SAKK 60-00 Trial
- (2009) Arnaud D. Roth et al. JOURNAL OF CLINICAL ONCOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search